Homocystinuria Market, Global Outlook and Forecast 2022-2028

May 2022 | 63 pages | ID: HCCAD435D1A1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Homocystinuria in Global, including the following market information:

Global Homocystinuria Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Homocystinuria market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Homocystinuria include BASF SE, HUAZHONG PHARMACEUTICAL Co. Ltd., Pfizer Inc., MYLAN N.V., Aeglea BioTherapeutics, Amino GMBH, KAO Corporation, DSM Corporation and Orphan Technologies and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Homocystinuria companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Homocystinuria Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Homocystinuria Market Segment Percentages, by Type, 2021 (%)

• Diagnosis
• Treatment

Global Homocystinuria Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Homocystinuria Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Diagnostic and Imaging Laboratories
• Academic and Research Institutes
• Others

Global Homocystinuria Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Homocystinuria Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Homocystinuria revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Homocystinuria revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• BASF SE
• HUAZHONG PHARMACEUTICAL Co. Ltd.
• Pfizer Inc.
• MYLAN N.V.
• Aeglea BioTherapeutics
• Amino GMBH
• KAO Corporation
• DSM Corporation
• Orphan Technologies
• Fresenius Kabi AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Homocystinuria Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Homocystinuria Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HOMOCYSTINURIA OVERALL MARKET SIZE

2.1 Global Homocystinuria Market Size: 2021 VS 2028
2.2 Global Homocystinuria Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Homocystinuria Players in Global Market
3.2 Top Global Homocystinuria Companies Ranked by Revenue
3.3 Global Homocystinuria Revenue by Companies
3.4 Top 3 and Top 5 Homocystinuria Companies in Global Market, by Revenue in 2021
3.5 Global Companies Homocystinuria Product Type
3.6 Tier 1, Tier 2 and Tier 3 Homocystinuria Players in Global Market
  3.6.1 List of Global Tier 1 Homocystinuria Companies
  3.6.2 List of Global Tier 2 and Tier 3 Homocystinuria Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Homocystinuria Market Size Markets, 2021 & 2028
  4.1.2 Diagnosis
  4.1.3 Treatment
4.2 By Type - Global Homocystinuria Revenue & Forecasts
  4.2.1 By Type - Global Homocystinuria Revenue, 2017-2022
  4.2.2 By Type - Global Homocystinuria Revenue, 2023-2028
  4.2.3 By Type - Global Homocystinuria Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Homocystinuria Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Diagnostic and Imaging Laboratories
  5.1.5 Academic and Research Institutes
  5.1.6 Others
5.2 By Application - Global Homocystinuria Revenue & Forecasts
  5.2.1 By Application - Global Homocystinuria Revenue, 2017-2022
  5.2.2 By Application - Global Homocystinuria Revenue, 2023-2028
  5.2.3 By Application - Global Homocystinuria Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Homocystinuria Market Size, 2021 & 2028
6.2 By Region - Global Homocystinuria Revenue & Forecasts
  6.2.1 By Region - Global Homocystinuria Revenue, 2017-2022
  6.2.2 By Region - Global Homocystinuria Revenue, 2023-2028
  6.2.3 By Region - Global Homocystinuria Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Homocystinuria Revenue, 2017-2028
  6.3.2 US Homocystinuria Market Size, 2017-2028
  6.3.3 Canada Homocystinuria Market Size, 2017-2028
  6.3.4 Mexico Homocystinuria Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Homocystinuria Revenue, 2017-2028
  6.4.2 Germany Homocystinuria Market Size, 2017-2028
  6.4.3 France Homocystinuria Market Size, 2017-2028
  6.4.4 U.K. Homocystinuria Market Size, 2017-2028
  6.4.5 Italy Homocystinuria Market Size, 2017-2028
  6.4.6 Russia Homocystinuria Market Size, 2017-2028
  6.4.7 Nordic Countries Homocystinuria Market Size, 2017-2028
  6.4.8 Benelux Homocystinuria Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Homocystinuria Revenue, 2017-2028
  6.5.2 China Homocystinuria Market Size, 2017-2028
  6.5.3 Japan Homocystinuria Market Size, 2017-2028
  6.5.4 South Korea Homocystinuria Market Size, 2017-2028
  6.5.5 Southeast Asia Homocystinuria Market Size, 2017-2028
  6.5.6 India Homocystinuria Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Homocystinuria Revenue, 2017-2028
  6.6.2 Brazil Homocystinuria Market Size, 2017-2028
  6.6.3 Argentina Homocystinuria Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Homocystinuria Revenue, 2017-2028
  6.7.2 Turkey Homocystinuria Market Size, 2017-2028
  6.7.3 Israel Homocystinuria Market Size, 2017-2028
  6.7.4 Saudi Arabia Homocystinuria Market Size, 2017-2028
  6.7.5 UAE Homocystinuria Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 BASF SE
  7.1.1 BASF SE Corporate Summary
  7.1.2 BASF SE Business Overview
  7.1.3 BASF SE Homocystinuria Major Product Offerings
  7.1.4 BASF SE Homocystinuria Revenue in Global Market (2017-2022)
  7.1.5 BASF SE Key News
7.2 HUAZHONG PHARMACEUTICAL Co. Ltd.
  7.2.1 HUAZHONG PHARMACEUTICAL Co. Ltd. Corporate Summary
  7.2.2 HUAZHONG PHARMACEUTICAL Co. Ltd. Business Overview
  7.2.3 HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Major Product Offerings
  7.2.4 HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Revenue in Global Market (2017-2022)
  7.2.5 HUAZHONG PHARMACEUTICAL Co. Ltd. Key News
7.3 Pfizer Inc.
  7.3.1 Pfizer Inc. Corporate Summary
  7.3.2 Pfizer Inc. Business Overview
  7.3.3 Pfizer Inc. Homocystinuria Major Product Offerings
  7.3.4 Pfizer Inc. Homocystinuria Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Inc. Key News
7.4 MYLAN N.V.
  7.4.1 MYLAN N.V. Corporate Summary
  7.4.2 MYLAN N.V. Business Overview
  7.4.3 MYLAN N.V. Homocystinuria Major Product Offerings
  7.4.4 MYLAN N.V. Homocystinuria Revenue in Global Market (2017-2022)
  7.4.5 MYLAN N.V. Key News
7.5 Aeglea BioTherapeutics
  7.5.1 Aeglea BioTherapeutics Corporate Summary
  7.5.2 Aeglea BioTherapeutics Business Overview
  7.5.3 Aeglea BioTherapeutics Homocystinuria Major Product Offerings
  7.5.4 Aeglea BioTherapeutics Homocystinuria Revenue in Global Market (2017-2022)
  7.5.5 Aeglea BioTherapeutics Key News
7.6 Amino GMBH
  7.6.1 Amino GMBH Corporate Summary
  7.6.2 Amino GMBH Business Overview
  7.6.3 Amino GMBH Homocystinuria Major Product Offerings
  7.6.4 Amino GMBH Homocystinuria Revenue in Global Market (2017-2022)
  7.6.5 Amino GMBH Key News
7.7 KAO Corporation
  7.7.1 KAO Corporation Corporate Summary
  7.7.2 KAO Corporation Business Overview
  7.7.3 KAO Corporation Homocystinuria Major Product Offerings
  7.7.4 KAO Corporation Homocystinuria Revenue in Global Market (2017-2022)
  7.7.5 KAO Corporation Key News
7.8 DSM Corporation
  7.8.1 DSM Corporation Corporate Summary
  7.8.2 DSM Corporation Business Overview
  7.8.3 DSM Corporation Homocystinuria Major Product Offerings
  7.8.4 DSM Corporation Homocystinuria Revenue in Global Market (2017-2022)
  7.8.5 DSM Corporation Key News
7.9 Orphan Technologies
  7.9.1 Orphan Technologies Corporate Summary
  7.9.2 Orphan Technologies Business Overview
  7.9.3 Orphan Technologies Homocystinuria Major Product Offerings
  7.9.4 Orphan Technologies Homocystinuria Revenue in Global Market (2017-2022)
  7.9.5 Orphan Technologies Key News
7.10 Fresenius Kabi AG
  7.10.1 Fresenius Kabi AG Corporate Summary
  7.10.2 Fresenius Kabi AG Business Overview
  7.10.3 Fresenius Kabi AG Homocystinuria Major Product Offerings
  7.10.4 Fresenius Kabi AG Homocystinuria Revenue in Global Market (2017-2022)
  7.10.5 Fresenius Kabi AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Homocystinuria Market Opportunities & Trends in Global Market
Table 2. Homocystinuria Market Drivers in Global Market
Table 3. Homocystinuria Market Restraints in Global Market
Table 4. Key Players of Homocystinuria in Global Market
Table 5. Top Homocystinuria Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Homocystinuria Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Homocystinuria Revenue Share by Companies, 2017-2022
Table 8. Global Companies Homocystinuria Product Type
Table 9. List of Global Tier 1 Homocystinuria Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Homocystinuria Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Homocystinuria Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Homocystinuria Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Homocystinuria Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Homocystinuria Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Homocystinuria Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Homocystinuria Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Homocystinuria Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Homocystinuria Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Homocystinuria Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Homocystinuria Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Homocystinuria Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Homocystinuria Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Homocystinuria Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Homocystinuria Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Homocystinuria Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Homocystinuria Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Homocystinuria Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Homocystinuria Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Homocystinuria Revenue, (US$, Mn), 2023-2028
Table 30. BASF SE Corporate Summary
Table 31. BASF SE Homocystinuria Product Offerings
Table 32. BASF SE Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 33. HUAZHONG PHARMACEUTICAL Co. Ltd. Corporate Summary
Table 34. HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Product Offerings
Table 35. HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Inc. Corporate Summary
Table 37. Pfizer Inc. Homocystinuria Product Offerings
Table 38. Pfizer Inc. Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 39. MYLAN N.V. Corporate Summary
Table 40. MYLAN N.V. Homocystinuria Product Offerings
Table 41. MYLAN N.V. Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 42. Aeglea BioTherapeutics Corporate Summary
Table 43. Aeglea BioTherapeutics Homocystinuria Product Offerings
Table 44. Aeglea BioTherapeutics Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 45. Amino GMBH Corporate Summary
Table 46. Amino GMBH Homocystinuria Product Offerings
Table 47. Amino GMBH Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 48. KAO Corporation Corporate Summary
Table 49. KAO Corporation Homocystinuria Product Offerings
Table 50. KAO Corporation Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 51. DSM Corporation Corporate Summary
Table 52. DSM Corporation Homocystinuria Product Offerings
Table 53. DSM Corporation Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 54. Orphan Technologies Corporate Summary
Table 55. Orphan Technologies Homocystinuria Product Offerings
Table 56. Orphan Technologies Homocystinuria Revenue (US$, Mn), (2017-2022)
Table 57. Fresenius Kabi AG Corporate Summary
Table 58. Fresenius Kabi AG Homocystinuria Product Offerings
Table 59. Fresenius Kabi AG Homocystinuria Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Homocystinuria Segment by Type in 2021
Figure 2. Homocystinuria Segment by Application in 2021
Figure 3. Global Homocystinuria Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Homocystinuria Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Homocystinuria Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Homocystinuria Revenue in 2021
Figure 8. By Type - Global Homocystinuria Revenue Market Share, 2017-2028
Figure 9. By Application - Global Homocystinuria Revenue Market Share, 2017-2028
Figure 10. By Region - Global Homocystinuria Revenue Market Share, 2017-2028
Figure 11. By Country - North America Homocystinuria Revenue Market Share, 2017-2028
Figure 12. US Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Homocystinuria Revenue Market Share, 2017-2028
Figure 16. Germany Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 17. France Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Homocystinuria Revenue Market Share, 2017-2028
Figure 24. China Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 28. India Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Homocystinuria Revenue Market Share, 2017-2028
Figure 30. Brazil Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Homocystinuria Revenue Market Share, 2017-2028
Figure 33. Turkey Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Homocystinuria Revenue, (US$, Mn), 2017-2028
Figure 37. BASF SE Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. HUAZHONG PHARMACEUTICAL Co. Ltd. Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Inc. Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. MYLAN N.V. Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aeglea BioTherapeutics Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amino GMBH Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. KAO Corporation Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DSM Corporation Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Orphan Technologies Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Fresenius Kabi AG Homocystinuria Revenue Year Over Year Growth (US$, Mn) & (2017-2022)